A report on the Automated External Defibrillators Market has been recently published by Stratview Research. This Market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Automated External Defibrillators Market. The historic years considered for the study are 2017-2020, the base year is 2021, and the forecast period is 2022-2028.

The study includes an in-depth analysis of type, application, and regional segments. It also includes a Market channel, distribution, and customer analysis, industry cost analysis, Market analysis by application, production, revenue, and price trend analysis by type, production and consumption analysis by region, and various other Market studies.

Market Analysis

The automated external defibrillators market was estimated at USD 1.71 billion in 2021 and is likely to grow at a CAGR of 7.05% during 2022-2028 to reach USD 2.77 billion in 2028.

Market Drivers

The rapidly expanding aging population has also resulted in increased demands for automated external defibrillators.

  • The market growth is primarily driven by an increase in the number of people suffering from cardiovascular diseases as a result of a busy lifestyle and unhealthy eating habits.
  • The rise in the number of people dying due to cardiac arrest is likely to fuel the demand for automated defibrillators at a significant rate.
  • Growing emphasis on technological advancement in these devices is expected to create lucrative opportunities for the players operating in the global automated external defibrillators market during the review period.

Key Segments Automated External Defibrillators Market Report Covers:

Based on end users, the market has been divided into hospitals, public access, emergency medical services, homes, and private cardiac clinics.

In 2021, the hospital's segment garnered the largest market share. The public access segment is likely to grow at a significant rate during the review period on account of the rise in the number of sudden cardiac arrest cases worldwide.

Based on technology type, the market is segmented as semi-automatic and fully automatic. The fully automatic segment is estimated to account for the major share of the market during the forecast period.

The market in North America accounted for the largest share of approximately 30% in 2021.

This was due to the increasing geriatric population, the rise in the number of people dying due to cardiac arrest, and the growing emphasis on technological advancement in defibrillators.

The market in the Asia-Pacific region is projected to register a healthy growth rate on account of rising product awareness among consumers and expanding the healthcare industry in developing countries.

Report Customization –

This report can be customized to meet the client’s obligations. Please get along with our sales team ([email protected]), who will ensure that you get a report that fits your needs. You can also touch a chord with our executives at +1-313-307-4176 to share your research constraints.

Key players operating in the Automated External Defibrillators market are-

  • Koninklijke Philips N.V. (Netherlands),
  • Physio-Control Corporation (The U.S),
  • Asahi Kasei Medical Co., Ltd (Japan),
  • Nihon Kohden Corporation (Japan),
  • Schiller AG (Switzerland),
  • Mindray Medical International Limited (China),
  • GE Healthcare (The U.S),
  • Stryker Corporation (The U.S),
  • Cardiac Science Corporation (The U.S),
  • Zoll Medical Corporation (The U.S),
  • Me­trax GmbH (Germany), and
  • Biotronik (Germany).

About Us –

Stratviewresearch.com is a leading global Market Research firm providing expert research solutions, trusted by clients worldwide. Stratview Research possesses a global presence to enable current Market information using the most up-to-date methodology, best-in-class research techniques, and cost-effective approaches. We survey clients in several countries to provide you with the most comprehensive illustration of global trends and behaviours.